Growth AlterationNCT03363802
Assessment of Pubertal Growth Spurt in Growing Girls Using Middle Phalynx Finger and Correlate With Mandibular Second Molar
An observational study of Growth Alteration, run by Cairo University at 1 site in Egypt.
Trial summary
Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar Read more about this study
- Who is it for?
- Ages 9 to 14 years, women only
- Conditions the study is for
- Growth Alteration
- How many people
- 1,600 participants
- Where
- 1 siteEgypt
- Study dates
- 10 Feb 2018to Apr 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 9 to 14 years
- Women only
- Child
Study population: Egyptian females between 9-14 years old to be sure that they are within or around the circumpubertal period.
Who may be able to join
- Egyptian citizen
Who cannot join
- Systemic disease and syndromes
- Severe crowding
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar in Al Sharkia Governorate
Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar
Read the detailed description
The sample will be selected randomly from different schools in the government.
- Digital periapical radiograph for the middle finger for each participants will be taken using Digital x-ray portable machine.
- Radiographical images will be stored in a digital sensor to be transferred to computer then we asses growth spurt in girls and correlate it with devlopemt stage of mandibular second molar
- Conditions
- Growth Alteration
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of the time of pubertal growth spurt in growing Egyptian
Taking xray of middle phalynx finger and then asses age of growth spurt through stages of middle phalynx finger
Measured: 3month
Secondary outcomes (1)
females. Assessment the correlation between the modified middle phalanx of the middle finger and development stage of mandibular second molar
By taking xray mandibular second molar then make correlation between stages of both to estimate age for pubertal growth spurt for females
Measured: 3month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Dec 2017
- Study start10 Feb 2018 (estimated)
- Primary completionMar 2018 (estimated)
- Study completionApr 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Growth AlterationStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mahmoud Magdy, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03363802
- Sponsor's protocol ID
- CEBC-CU-2017-12-01
- Status last verified
- Dec 2017
- First submitted
- 1 Dec 2017
- Last updated
- 7 Dec 2017
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Dec 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar in Al Sharkia Governorate
- ClinicalTrials.gov ID
- NCT03363802
- Acronym / sponsor ID
- CEBC-CU-2017-12-01
- Conditions
- Growth Alteration
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,600 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 10 Feb 2018 (estimated)
- Primary completion
- Mar 2018 (estimated)
- Study completion
- Apr 2018 (estimated)
- First posted
- 6 Dec 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar
Detailed description
The sample will be selected randomly from different schools in the government.
- Digital periapical radiograph for the middle finger for each participants will be taken using Digital x-ray portable machine.
- Radiographical images will be stored in a digital sensor to be transferred to computer then we asses growth spurt in girls and correlate it with devlopemt stage of mandibular second molar
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 9 to 14 years
- Sex
- Female only
- Age groups
- Child
- Study population
- Egyptian females between 9-14 years old to be sure that they are within or around the circumpubertal period.
Key inclusion criteria (1 listed)
- Egyptian citizen
Key exclusion criteria (2 listed)
- Systemic disease and syndromes
- Severe crowding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Assessment of the time of pubertal growth spurt in growing Egyptian
Time frame: 3month
Taking xray of middle phalynx finger and then asses age of growth spurt through stages of middle phalynx finger
1 secondary outcome
females. Assessment the correlation between the modified middle phalanx of the middle finger and development stage of mandibular second molar
Time frame: 3month
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Dec 2017.
Related trials for Growth Alteration
RecruitingPhase 1/2
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Advanced Solid Tumor
RecruitingPhase 1
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Solid Tumor, Adult, Non-small Cell Lung Cancer
Active, not recruitingPhase 2
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)
Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma
Not yet recruitingObservational study
Catch up Growth Of Children After Closure Of Hemodinamically Significant Large VSD In Assuit University Children Hospital
Growth Alteration
Active, not recruitingPhase 1/2
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Growth Alteration, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of the time of pubertal growth spurt in growing Egyptian (time frame: 3month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2017.